C12Y 203/01005
Arylamine n-acetyltransferase
Official title: Arylamine N-acetyltransferase (2.3.1.5)
C12Y203/01005 (Arylamine n-acetyltransferase) appears on 7 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 12
- Assignees
- 8
- Inventors
- 25
- Latest grant
- 6 Feb 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 2 | 1 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 3 |
| 2024 | 1 | 1 |
By publication year.
Recent patents
- Prenylated psilocybin derivatives and methods of using6 Feb 2024US 11,891,359 B2Enveric Biosciences Canada Inc.
- Cell-based production of nonulosonates28 May 2019US 10,301,659 B2National Research Council of Canada
- Cell-based production of nonulosonates6 Dec 2016US 9,512,455 B2National Research Council of Canada
- Puro-DHFR quadrifunctional marker and its use in protein production3 Nov 2015US 9,175,284 B2Merck Serono SA
- Cell-based production of nonulosonates23 Sep 2014US 8,841,099 B2National Research Council of Canada
- Recombinant microorganism having diamine producing ability and method for manufacturing diamine1 Aug 2024US 2024/0254524 A1Asahi Kasei Kabushiki Kaisha
- Microorganism for producing putrescine and process for producing putrescine by using same7 Dec 2023US 2023/0392174 A1Cj Cheiljedang Corporation
- Prenylated psilocybin derivatives and methods of using13 Jul 2023US 2023/0219888 A1Enveric Biosciences Canada Inc.
- Nitrated psilocybin derivatives and methods of using9 Feb 2023US 2023/0040398 A1Enveric Biosciences Canada Inc.
- Methods and compositions for inhibiting necroptosis in neurovascular and/or neurodegenerative diseases or disorders20 May 2021US 2021/0147842 A1President and Fellows of Harvard College
Most cited
By later US patents